Inhaled Formoterol-Fluticasone Single Inhaler Therapy in Asthma: Real-World Efficacy, Budget Impact, and Potential to Improve Adherence
Asthma is the commonest chronic disease affecting airways in humans and has an increasing global disease burden. Inhaled corticosteroids (ICS) are the first-line therapeutic option for asthma, and addition of a long-acting beta 2-agonist (LABA) has been shown to improve asthma control. A combination...
Main Authors: | V. Rajesh, Jolsana Augustine, R. Divya, Melcy Cleetus |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2020/8631316 |
Similar Items
-
COMPARATIVE EFFICACY OF INHALED DRUGS FORMOTEROL / BECLOMETHASONE AND FORMOTEROL / BUDESONIDE AND BRONCHIAL ASTHMA
by: V. A. Nikitin, et al.
Published: (2016-03-01) -
Efficacy of Omalizumab Therapy in an Asthmatic with Low IgE
by: Divya R, et al.
Published: (2020-01-01) -
Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review
by: Halpin David MG, et al.
Published: (2006-06-01) -
Efficacy and safety of single-inhaler triple therapy of glycopyrronium, formoterol and fluticasone in patients with COPD: a double-blind, randomised controlled trial
by: Sundeep Salvi, et al.
Published: (2021-07-01) -
COVID-19 presenting as acute transient flaccid limb paralysis
by: V Rajesh, et al.
Published: (2021-01-01)